PillRx only · Capsule, Delayed Release · Oral
Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
Brands: Pancreaze · Pancrelipase Amylase + Pancrelipase Lipase + Pancrelipase Protease
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US6 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| VIVUS LLC | unknown | 6 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 23, 2023RECALLRecall (Class III): PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Camp…
Failed Stability Specifications — Recalling firm: Vivus, Inc. — Nationwide within the United States